![Adam Logal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adam Logal
Finanzdirektor/CFO bei
OPKO HEALTH, INC.
Vermögen: 828 192 $ am 31.08.2026
Profil
Mr. Adam E.
Logal is a CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. He is on the Board of Directors at Non-Invasive Monitoring Systems, Inc., Bio-Reference Laboratories, Inc. and OPKO Biologics Ltd. Mr. Logal was previously employed as a President by GeneDx LLC, a Chairman by Xenetic Biosciences, Inc., an Independent Director by VBI Vaccines, Inc., a Finance Director, Secretary, Treasurer & CAO by eXegenics, Inc., and a Chief Financial & Accounting Officer by Nabi Biopharmaceuticals.
He also served on the board at SciVac Therapeutics, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OPKO HEALTH, INC. 0.08% | 24.07.2026 | 563’396 ( 0.08% ) | 828 192 $ | 31.08.2026 |
Aktive Positionen von Adam Logal
| Unternehmen | Position | Beginn |
|---|---|---|
| OPKO HEALTH, INC. | Finanzdirektor/CFO | 01.07.2012 |
| BIO-REFERENCE LABORATORIES INC | Direktor/Vorstandsmitglied | 20.08.2015 |
| NON-INVASIVE MONITORING SYSTEMS, INC. | Direktor/Vorstandsmitglied | 03.09.2025 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Direktor/Vorstandsmitglied | 01.04.2014 |
Ehemalige bekannte Positionen von Adam Logal
| Unternehmen | Position | Ende |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Vorsitzender | 11.12.2024 |
GeneDx LLC
 GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Präsident | 01.06.2021 |
| VBI VACCINES INC. | Direktor/Vorstandsmitglied | 01.10.2018 |
eXegenics, Inc.
 eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Finanzdirektor/CFO | 13.06.2007 |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Finanzdirektor/CFO | 01.01.2007 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Bio-Reference Laboratories, Inc.
 Bio-Reference Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing services | Commercial Services |
Non-Invasive Monitoring Systems, Inc.
 Non-Invasive Monitoring Systems, Inc. Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
eXegenics, Inc.
eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
OPKO Health, Inc.
 OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
SciVac Therapeutics, Inc.
 SciVac Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Health Services |
